Cargando…
Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434020/ https://www.ncbi.nlm.nih.gov/pubmed/32433343 http://dx.doi.org/10.1097/JCMA.0000000000000356 |
_version_ | 1783572061471375360 |
---|---|
author | Li, Szu-Yuan Tang, Yu-Shuo Chan, Yu-Jiun Tarng, Der-Cherng |
author_facet | Li, Szu-Yuan Tang, Yu-Shuo Chan, Yu-Jiun Tarng, Der-Cherng |
author_sort | Li, Szu-Yuan |
collection | PubMed |
description | A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-7434020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-74340202020-08-18 Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease Li, Szu-Yuan Tang, Yu-Shuo Chan, Yu-Jiun Tarng, Der-Cherng J Chin Med Assoc Review Articles A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week treatment is inevitable for all hemodialysis patients. In addition to the high risk of cluster infection and compromised immunity in patients with end-stage renal disease (ESRD), an atypical disease presentation could also make the medial system neglect these patients during CVOID-19 pandemic. To avoid COVID-19 transmission among patients on dialysis, the major societies of nephrology around the world have provided their guidelines for screening, dialysis facilities adjustment, and health education, respectively. In this review, we summarized the main contents and differences of these guidelines and addressed the prompt management for patients with ESRD to reduce the risk of infection during COVID-19 pandemic. Lippincott Williams & Wilkins 2020-05-19 2020-07 /pmc/articles/PMC7434020/ /pubmed/32433343 http://dx.doi.org/10.1097/JCMA.0000000000000356 Text en Copyright © 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Review Articles Li, Szu-Yuan Tang, Yu-Shuo Chan, Yu-Jiun Tarng, Der-Cherng Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title | Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title_full | Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title_fullStr | Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title_full_unstemmed | Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title_short | Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease |
title_sort | impact of the covid-19 pandemic on the management of patients with end-stage renal disease |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434020/ https://www.ncbi.nlm.nih.gov/pubmed/32433343 http://dx.doi.org/10.1097/JCMA.0000000000000356 |
work_keys_str_mv | AT liszuyuan impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease AT tangyushuo impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease AT chanyujiun impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease AT tarngdercherng impactofthecovid19pandemiconthemanagementofpatientswithendstagerenaldisease |